Globus Medical, Inc. (GMED) Q1 2016 Earnings Results

Globus Med Inc Class A Beats on EPS, Stock Down 0.75%

Globus Med Inc's earnings report showed a small EPS beat, but the stock reacted negatively, declining by 0.75%. The lack of revenue data and guidance may have contributed to investor uncertainty. Management's cautious tone suggests they are focused on maintaining efficiency and developing their product pipeline moving forward.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.29	N/A	+2.11%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding future performance. They emphasized operational efficiency and product development.

Management highlighted the importance of maintaining operational efficiency.

They expressed confidence in their product pipeline despite not providing specific guidance.

Globus Med Inc Class A Beats on EPS, Stock Down 0.75%

Key numbers

Management commentary

Globus Medical, Inc.

More earnings this week

Globus Med Inc Class A Beats on EPS, Stock Down 0.75%

Key numbers

Management commentary